Anna Rolando
Merck & Co., Inc., Rahway, NJ, USA (United States)(US)
Publications by Year
Research Areas
Melanoma and MAPK Pathways, Synthesis and biological activity, Peptidase Inhibition and Analysis, Protein Kinase Regulation and GTPase Signaling, Computational Drug Discovery Methods
Most-Cited Works
- → A novel heterodimeric cysteine protease is required for interleukin-1βprocessing in monocytes(1992)2,559 cited
- → The Activation State of p38 Mitogen-Activated Protein Kinase Determines the Efficiency of ATP Competition for Pyridinylimidazole Inhibitor Binding(1998)200 cited
- → Design and Synthesis of Potent, Selective, and Orally Bioavailable Tetrasubstituted Imidazole Inhibitors of p38 Mitogen-Activated Protein Kinase(1999)196 cited
- → Pyrroles and other heterocycles as inhibitors of P38 kinase(1998)117 cited
- → Purification and characterization of active human interleukin-1 beta-converting enzyme from THP.1 monocytic cells.(1993)112 cited
- → Substituted Imidazoles as Glucagon Receptor Antagonists(2001)108 cited
- → Kinetic Mechanism for p38 MAP Kinase(1997)103 cited
- → Interleukin 1 beta (IL-1 beta) processing in murine macrophages requires a structurally conserved homologue of human IL-1 beta converting enzyme.(1993)61 cited
- → The Structure and Complete Nucleotide Sequence of the Murine Gene Encoding Interleukin-1β Converting Enzyme (ICE)(1994)61 cited